Back to Journals » Cancer Management and Research » Volume 11
Original Research
CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,259 | Dovepress* | 4,348+ | 931 | 5,279 | |
PubMed Central* | 911 | 192 | 1,103 | ||
Totals | 5,259 | 1,123 | 6,382 | ||
*Since 15 April 2019 |
View citations on PubMed Central and Google Scholar